Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis von Dulai, Parambir S., Singh, Siddharth, Patel, Janki, Soni, Meera, Prokop, Larry J., Younossi, Zobair, Sebastiani, Giada, Ekstedt, Mattias, Hagstrom, Hannes, Nasr, Patrik, Stal, Per, Wong, Vincent Wai‐Sun, Kechagias, Stergios, Hultcrantz, Rolf, Loomba, Rohit

Volltext

EE406 Economic Impact of Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis: Induction and Maintenance Phase 3 Results on Work Productivity... von Yu, T, Dulai, PS, Griffith, J, Sharma, D, Loftus, EV

Volltext

PCR158 Assessing the Cost of Work Productivity Loss in a Privately Insured US Population With Inflammatory Bowel Diseases von Yu, T, Dulai, PS, Griffith, J, Sharma, D, Loftus, EV

Volltext

Editorial: combination immunosuppressive therapy to treat Crohn’s disease – ready for all age groups? Authors' reply von Singh, Siddharth, Jairath, Vipul, LW, Stitt, G, Zou, R, Khanna, PS, Dulai, WJ, Sandborn, BG, Feagan

Volltext